glp-1 and surgery risk Metabolic bariatric versus glucagon-like peptide-1 receptor agonist therapy: A comparison of cardiovascular outcomes in patients with obesity GLP-1 Drugs vs. Bariatric Surgery
Description
Additionally, the Roux-en-Y gastric bypass may alter gut hormones involved in appetite regulation, further contributing to feelings of fullness and reduced hunger
That for some reason, that dosage, I don't know
Discovery and development of exenatide: The first antidiabetic agent to leverage the multiple benefits of the incretin hormone, GLP-1
Oury C, Marechal P, Donis N, Hulin A, Hego A, Tridetti J, et al
Park, D
